NDC 71288-201
Regadenoson
Regadenoson
Regadenoson is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is Regadenoson.
Product ID | 71288-201_347eb6ed-dadc-4127-be90-24f65150fbff |
NDC | 71288-201 |
Product Type | Human Prescription Drug |
Proprietary Name | Regadenoson |
Generic Name | Regadenoson |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-04-11 |
Marketing Category | ANDA / |
Application Number | ANDA212806 |
Labeler Name | Meitheal Pharmaceuticals Inc. |
Substance Name | REGADENOSON |
Active Ingredient Strength | 0 mg/mL |
Pharm Classes | Adenosine Receptor Agonists [MoA], Pharmacologic Cardiac Stress Test Agent [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |